...
首页> 外文期刊>International Journal of Biological Macromolecules: Structure, Function and Interactions >In vitro and in vivo release of diclofenac sodium-loaded sodium alginate/carboxymethyl chitosan-ZnO hydrogel beads
【24h】

In vitro and in vivo release of diclofenac sodium-loaded sodium alginate/carboxymethyl chitosan-ZnO hydrogel beads

机译:在体外和体内释放双氯芬酸钠钠藻酸钠/羧甲基壳聚糖 - ZnO水凝胶珠

获取原文
获取原文并翻译 | 示例
           

摘要

To control release of drugs sensitive to gastrointestinal (GI) environmental effects or irritating to stomach, such as diclofenac sodium (DS), sodium alginate (SA) hydrogel beads are gaining considerable attention gradually. However, due to high swelling ratio, the sustained release performance of SA hydrogel is still far from satisfactory. The objective of this research was to develop new drug delivery device based on SA and ZnO nanoparticles (ZnO NPs). ZnO NPs were prepared by direct precipitation method, and carboxymethyl chitosan (CMCS) acted as stabilizing agent to dominate the preparation of ZnO NPs. The incorporation of CMCS-ZnO NPs resulted in slower and sustained release of DS in vitro. In vivo pharmacokinetics studies showed the bioavailability of DS was better after oral administration of DS-loaded SA/CMCS-ZnO hydrogel beads. These results suggested that SA/CMCS-ZnO hydrogel beads will be a prospective material for loading drugs sensitive to GI environmental effects or irritating to stomach. (C) 2019 Elsevier B.V. All rights reserved.
机译:为了控制对胃肠道(GI)环境影响敏感的药物释放或刺激胃,例如双氯芬酸钠(DS),藻酸钠(SA)水凝胶珠粒逐渐获得大量关注。然而,由于高溶胀比,SA水凝胶的持续释放性能仍然远非令人满意。该研究的目的是基于SA和ZnO纳米颗粒(ZnO NPS)开发新的药物递送装置。通过直接沉淀法制备ZnO NPS,羧甲基壳聚糖(CMC)作用为稳定剂以支配ZnO NP的制备。 CMCS-ZnO NPS的掺入导致体外较慢和持续释放DS。在体内药代动力学研究表明,在口服施用DS加载的SA / CMCS-ZnO水凝胶珠粒后,DS的生物利用度更好。这些结果表明SA / CMCS-ZnO水凝胶珠粒将是加载对GI环境影响或刺激胃敏感的药物的前瞻性材料。 (c)2019 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号